Brooks Michael J
Known title: PresidentCIK: 0001779126
Brooks Michael J's purchase track record
How the stock did after each of Brooks Michael J's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
5
of 5 since March 8, 2022
Stock higher 6 months later
40%
3 months: 60%
Median 6-month return
-40.9%
3 months: +6.7%
Beat the S&P 500
40%
median -34.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/26/2026 | EDSA | $3K | +407.1% | +196.8% | +11.9% |
| 6/29/2022 | EDSA | $4K | -6.1% | +25.0% | -0.9% |
| 6/16/2022 | EDSA | $5K | +6.7% | -41.8% | +6.2% |
| 5/25/2022 | EDSA | $6K | +7.5% | -49.4% | +1.2% |
| 3/8/2022 | EDSA | $10K | -31.1% | -40.9% | -6.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| EDSA | ▲ Buy | Grant | 64,609 | $0 | 5/27/2026 | View on chart |
| EDSA | ▲ Buy | Open Market | 2,000 | $3K | 2/26/2026 | View on chart |
| EDSA | ▲ Buy | Grant | 207,201 | $0 | 5/29/2025 | View on chart |
| EDSA | ▲ Buy | Grant | 93,200 | — | 8/4/2023 | View on chart |
| EDSA | ▲ Buy | Grant | 4,239 | $5K | 11/2/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 3,000 | $4K | 6/29/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 3,000 | $5K | 6/16/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 3,500 | $6K | 5/25/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 1,250 | $3K | 3/14/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 1,000 | $3K | 3/10/2022 | View on chart |
| EDSA | ▲ Buy | Open Market | 1,250 | $4K | 3/8/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Edesa Biotech Included in After-Market Movers List
Edesa Biotech was highlighted in a recent list of healthcare stocks showing movement during Thursday's after-market session. The company trades well below its average analyst price target, with a 52-week range spanning from $0.72 to $20.32. This inclusion suggests increased attention from traders monitoring after-hours activity in the sector.
Edesa Biotech Included in After-Market Movers List. Edesa Biotech was highlighted in a recent list of healthcare stocks showing movement during Thursday's after-market session. The company trades well below its average analyst price target, with a 52-week range spanning from $0.72 to $20.32. This inclusion suggests increased attention from traders monitoring after-hours activity in the sector.